BLAS
GIL EXTREMERA
Investigador en el periodo 2018-2019
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (2)
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2013
-
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
New England Journal of Medicine, Vol. 369, Núm. 14, pp. 1317-1326